Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 2
Submit an article Journal homepage
1,753
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway

Lixin Chena School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin, ChinaView further author information
,
Ji Qianb Bio-teq Center, Fudan University, Shanghai, ChinaView further author information
,
Qinghua Youc Department of Pathology, Shanghai Pudong Hospital, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Jie Maa School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin, ChinaCorrespondence[email protected]
View further author information
Pages 10089-10100 | Received 08 Aug 2021, Accepted 27 Oct 2021, Published online: 10 Dec 2021

Related Research Data

LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.